![Gili Hart](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 6 214 $ al 31/05/2026
Gili Hart currently works at SpliSense Ltd., as Chief Executive Officer from 2020, Quicklizard Ltd., as Independent Director from 2021, and Enlivex Therapeutics Ltd., as Independent Director from 2014.
Dr. Hart also formerly worked at OPKO Biologics Ltd., as Chief Executive Officer from 2004 to 2017, Mitoconix Bio Ltd., as Chief Executive Officer from 2017 to 2020, Enlivex Therapeutics Ltd., as Director, CollPlant Biotechnologies Ltd., as Independent Director from 2021 to 2023, OPKO Health, Inc., as Vice President-Biologics, and Prolor Biotech Ltd., as VP-Pre-Clinical & Clinical Pharmacology from 2009 to 2013.
Dr. Hart received her graduate degree and doctorate degree from Weizmann Institute of Science and undergraduate degree from Technion Institute.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ENLIVEX LTD. 0 % | 18/03/2026 | 7.672 ( 0 % ) | 6 214 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ENLIVEX LTD. | Director/Miembro de la Junta | 01/01/2014 |
| QUICKLIZARD LTD | Director/Miembro de la Junta | 21/02/2021 |
SpliSense Ltd.
 SpliSense Ltd. Pharmaceuticals: MajorHealth Technology Develops antisense therapeutics for genetic diseases | Director Ejecutivo | 01/01/2020 |
| Empresas | Cargo | Fin |
|---|---|---|
| COLLPLANT BIOTECHNOLOGIES LTD. | Director/Miembro de la Junta | 05/07/2023 |
Mitoconix Bio Ltd.
 Mitoconix Bio Ltd. BiotechnologyHealth Technology Develops novel therapeutics to improve mitochondrial health as a disease-modifying therapeutics for neurodegenerative diseases | Director Ejecutivo | 01/01/2020 |
OPKO Biologics Ltd.
 OPKO Biologics Ltd. BiotechnologyHealth Technology Operates as a drug development company that develops bio-better long-acting therapeutic proteins | Director Ejecutivo | 01/01/2017 |
Prolor Biotech Ltd.
 Prolor Biotech Ltd. BiotechnologyHealth Technology Develops proprietary versions of already-approved therapeutic proteins | Corporate Officer/Principal | 01/01/2013 |
Enlivex Therapeutics Ltd. /Old/
 Enlivex Therapeutics Ltd. /Old/ Medical SpecialtiesHealth Technology Develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 11 |
|---|---|
OPKO Biologics Ltd.
OPKO Biologics Ltd. BiotechnologyHealth Technology Operates as a drug development company that develops bio-better long-acting therapeutic proteins | Health Technology |
Weizmann Institute of Science
 Weizmann Institute of Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OPKO Health, Inc.
 OPKO Health, Inc. Medical/Nursing ServicesHealth Services Engages in biopharmaceutical and diagnostics | Health Services |
Enlivex Therapeutics Ltd. /Old/
Enlivex Therapeutics Ltd. /Old/ Medical SpecialtiesHealth Technology Develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions | Health Technology |
CollPlant Biotechnologies Ltd.
 CollPlant Biotechnologies Ltd. Medical SpecialtiesHealth Technology Develops and commercializes medical devices | Health Technology |
Technion Institute
 Technion Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Quicklizard Ltd.
 Quicklizard Ltd. Packaged SoftwareTechnology Services Develops AI based pricing platform for e-Commerce and Omni channel retailers | Technology Services |
Prolor Biotech Ltd.
Prolor Biotech Ltd. BiotechnologyHealth Technology Develops proprietary versions of already-approved therapeutic proteins | Health Technology |
Mitoconix Bio Ltd.
Mitoconix Bio Ltd. BiotechnologyHealth Technology Develops novel therapeutics to improve mitochondrial health as a disease-modifying therapeutics for neurodegenerative diseases | Health Technology |
Enlivex Therapeutics Ltd.
 Enlivex Therapeutics Ltd. BiotechnologyHealth Technology Develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions | Health Technology |
SpliSense Ltd.
SpliSense Ltd. Pharmaceuticals: MajorHealth Technology Develops antisense therapeutics for genetic diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
